Masatsune Okajima

Masatsune Okajima

Masatsune Okajima Vice President and Head of Japanese Office Mr. Okajima joined MediciNova in September 2006. Before joining MediciNova, Mr.... More

See Masatsune Okajima:

Maria Feldman

Maria Feldman

female
Maria Feldman Director, Regulatory Affairs Maria Feldman has over 17 years of pharmaceutical industry experience. Ms. Feldman joined MediciNova,... More

See Maria Feldman:

Shintaro Asako

Shintaro Asako

Shintaro Asako Vice President and Chief Financial Officer Mr. Asako joined MediciNova in July 2005. Before joining MediciNova, he was an audit... More

See Shintaro Asako:

Upload_no_text

Jeff Himawan

male
Jeff Himawan , Ph.D. Chairman of the Board of Directors Dr. Himawan is Managing Director for Essex Woodlands Health Ventures.

See Jeff Himawan:

Upload_no_text

Arlene M. Morris

female
Arlene M. Morris Member of the Board of Directors Arlene Morris brings significant expertise in the establishment of strategic partnerships,... More

See Arlene M. Morris:

Yuichi Iwaki

Yuichi Iwaki

Yuichi Iwaki , M.D., Ph.D. President and Chief Executive Officer, and Founder Dr. Iwaki holds three professorships at the University of Southern... More

See Yuichi Iwaki:

Richard Gammans

Richard Gammans

male (Fayetteville, NC, United States)
Richard E. Gammans , Ph.D. Chief Development Officer Dr. Gammans has more than 25 years experience in drug discovery and development. Most... More

See Richard Gammans:

Kale Ruby

Kale Ruby

male (San Diego Area, CA, United States)
Kale Ruby Director, Quality Assurance Mr. Ruby has been involved in the pharmaceutical industry for the past eighteen years, having held quality... More

See Kale Ruby:

Kenneth Locke

Kenneth Locke

male
Dr. Kenneth Locke Chief Scientific Officer Dr. Locke has 20 years experience in drug discovery, preclinical and early clinical development. Dr.... More

See Kenneth Locke:

Upload_no_text

Alan W. Dunton

male
Dr Dunton is Chairman of ActivBiotics , and is on the boards of MediciNova and VWR International . He was formerly President and CEO of MetaPhore... More

See Alan W. Dunton: